RESUMO
BACKGROUND: Well-optimized treatment planning parameters are vital for optimum beam delivery in advanced radiotherapy techniques. The Elekta "Beam-Modulator" (BM) is a high-resolution multileaf collimation system where each individual leaf is 4 mm wide at the isocentre, without backup diaphragms and jaws. Its maximum aperture is 21 × 16 cm2, which results in a limited clinical use for the target geometry of maximum 20 cm in length. The collimator rotation provides an opportunity to treat slightly extended treatment length with optimal target coverage. The study aims to observe the collimator rotation influence on volumetric modulated arc therapy (VMAT) plan quality for different head and neck target geometries using limited field collimator of BM. METHODS: Ten patients with head and neck cancer were planned by means of simultaneous integrated boost to deliver VMAT for five patients with three dose levels (70/60/56) and five patients with two dose levels (60/54). The single arc, dual arc, and combined two independent single arcs of 356° each were well optimized for four collimator angles (C) 15°,30°, 45°, and 90°. The plans were prepared for BM with SmartArc module of Pinnacle³ treatment planning system. Statistical significance (P ≤ .05) among collimator angles for planning target volume dose-volume indices was calculated with Student's t-test. Organ-at-risk doses were compared and monitor units were also evaluated as a parameter for dose-delivery efficiency and out-of-field dose index. RESULTS: The dual arc and combined two independent single arcs achieved planning objectives for C15°, C30°, and C45°. Single arc for all collimator angles and C90° for all VMAT schemes failed to achieve planning objectives. The spread of low dose bath 20, 35, and 40 Gy and deterioration of doses were higher towards periphery at C90° and statistically significant. CONCLUSION: The small and medium collimator angles for dual-arc VMAT scheme(s) are suitable, whereas single arc and C90° are not suitable in VMAT implementation for Elekta Beam-Modulator collimation system.
Assuntos
Neoplasias de Cabeça e Pescoço/radioterapia , Dosagem Radioterapêutica , Adulto , Feminino , Neoplasias de Cabeça e Pescoço/patologia , Humanos , Masculino , Estadiamento de Neoplasias , Planejamento da Radioterapia Assistida por Computador/métodos , Radioterapia de Intensidade Modulada/métodos , RotaçãoRESUMO
The scope of this work was to apply a method for estimation of total scatter factors of the smallest beams of the Cyberknife radiosurgery system to newly available solid-state detectors: the PTW 60008 diode, the SunNuclear EdgeDetector diode, and the Thomson and Nielsen TN502RDM micromosfet. The method is based on a consistency check between Monte Carlo simulation of the detectors and experimental results, and was described in a recent publication. Corrected total scatter factors were in excellent agreement with the findings of the former study. The results showed that the diodes tend to overestimate the total scatter factor of small beams, probably due to excessive scatter from the material surrounding the active layer. The correction factor for diodes and for the micromosfet, however, was found to be independent of the electron beam width. This is a desirable characteristic because it allows standard correction factors to be used for treatment units of the same type, without the need of case-by-case Monte Carlo simulation.
Assuntos
Método de Monte Carlo , Radiocirurgia/métodos , Simulação por Computador , Desenho de Equipamento/instrumentação , Radiocirurgia/instrumentaçãoRESUMO
The scope of this study was to estimate total scatter factors (S(c,p)) of the three smallest collimators of the Cyberknife radiosurgery system (5-10 mm in diameter), combining experimental measurements and Monte Carlo simulation. Two microchambers, a diode, and a diamond detector were used to collect experimental data. The treatment head and the detectors were simulated by means of a Monte Carlo code in order to calculate correction factors for the detectors and to estimate total scatter factors by means of a consistency check between measurement and simulation. Results for the three collimators were: S(c,p) (5 mm) = 0.677 +/- 0.004, S(c,p) (7.5 mm) = 0.820 +/- 0.008, S(c,p) (10 mm) = 0.871 +/- 0.008, all relative to the 60 mm collimator at 80 cm source-to-detector distance. The method also allows the full width at half maximum of the electron beam to be estimated; estimations made with different collimators and different detectors were in excellent agreement and gave a value of 2.1 mm. Correction factors to be applied to the detectors for the measurement of S(c,p) were consistent with a prevalence of volume effect for the microchambers and the diamond and a prevalence of scattering from high-Z material for the diode detector. The proposed method is more sensitive to small variations of the electron beam diameter with respect to the conventional method used to commission Monte Carlo codes, i.e., by comparison with measured percentage depth doses (PDD) and beam profiles. This is especially important for small fields (less than 10 mm diameter), for which measurements of PDD and profiles are strongly affected by the type of detector used. Moreover, this method should allow S(c,p) of Cyberknife systems different from the unit under investigation to be estimated without the need for further Monte Carlo calculation, provided that one of the microchambers or the diode detector of the type used in this study are employed. The results for the diamond are applicable only to the specific detector that was investigated due to excessive variability in manufacturing.
Assuntos
Modelos Teóricos , Radiometria/instrumentação , Radiometria/métodos , Radiocirurgia/instrumentação , Radiocirurgia/métodos , Simulação por Computador , Desenho de Equipamento , Análise de Falha de Equipamento , Método de Monte Carlo , Dosagem Radioterapêutica , Espalhamento de RadiaçãoRESUMO
Volumetric-modulated arc therapy (VMAT) is an efficient form of radiotherapy used to deliver intensity-modulated radiotherapy beams. The aim of this study was to investigate the relative insensitivity of VMAT plan quality to gantry angle spacing (GS). Most previous VMAT planning and dosimetric work for GS resolution has been conducted for single arc VMAT. In this work, a quantitative comparison of dose-volume indices (DIs) was made for partial-, single- and double-arc VMAT plans optimized at 2°, 3° and 4° GS, representing a large variation in deliverable multileaf collimator segments. VMAT plans of six prostate cancer and six head-and-neck cancer patients were simulated for an Elekta SynergyS® Linac (Elekta Ltd, Crawley, UK), using the SmartArc™ module of Pinnacle³ TPS, (version 9.2, Philips Healthcare). All optimization techniques generated clinically acceptable VMAT plans, except for the single-arc for the head-and-neck cancer patients. Plan quality was assessed by comparing the DIs for the planning target volume, organs at risk and normal tissue. A GS of 2°, with finest resolution and consequently highest intensity modulation, was considered to be the reference, and this was compared with GS 3° and 4°. The differences between the majority of reference DIs and compared DIs were <2%. The metrics, such as treatment plan optimization time and pretreatment (phantom) dosimetric calculation time, supported the use of a GS of 4°. The ArcCHECK™ phantom-measured dosimetric agreement verifications resulted in a >95.0% passing rate, using the criteria for γ (3%, 3 mm). In conclusion, a GS of 4° is an optimal choice for minimal usage of planning resources without compromise of plan quality.
Assuntos
Planejamento da Radioterapia Assistida por Computador , Radioterapia de Intensidade Modulada , Relação Dose-Resposta à Radiação , Neoplasias de Cabeça e Pescoço/radioterapia , Humanos , Masculino , Órgãos em Risco , Neoplasias da Próstata/radioterapiaRESUMO
OBJECTIVE: To evaluate the tolerance of stereotactic body radiation therapy (SBRT) for the treatment of secondary lung tumours in patients who underwent previous pneumonectomy. METHODS: 12 patients were retrospectively analysed. The median maximum tumour diameter was 2.1 cm (1-4.5 cm). The median planning target volume was 20.7 cm(3) (2.4-101.2 cm(3)). Five patients were treated with a single fraction of 26 Gy and seven patients with fractionated schemes (3 × 10 Gy, 4 × 10 Gy, 4 × 12 Gy). Lung toxicity, correlated with volume (V) of lung receiving >5, >10 and >20 Gy, local control and survival rate were assessed. Median follow-up was 28 months. RESULTS: None of the patients experienced pulmonary toxicity > grade 2 at the median dosimetric lung parameters of V5, V10 and V20 of 23.1% (range 10.7-56.7%), 7.3% (2.2-27.2%) and 2.7% (0.7-10.9%), respectively. No patients required oxygen or had deterioration of the performance status during follow-up if not as a result of clinical progression of disease. The local control probability at 2 years was 64.5%, and the overall survival at 2 years was 80%. CONCLUSION: SBRT appears to be a safe and effective modality for treating patients with a second lung tumour after pneumonectomy. ADVANCES IN KNOWLEDGE: Our results and similar literature results show that when keeping V5, V10 V20 <50%, <20% and <7%, respectively, the risk of significant lung toxicity is acceptable. Our experience also shows that biologically effective dose 10 >100 Gy, necessary for high local control rate, can be reached while complying with the dose constraints for most patients.
Assuntos
Adenocarcinoma/cirurgia , Carcinoma de Células Escamosas/cirurgia , Neoplasias Pulmonares/cirurgia , Segunda Neoplasia Primária/cirurgia , Radiocirurgia/métodos , Adulto , Idoso , Idoso de 80 Anos ou mais , Fracionamento da Dose de Radiação , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Pneumonectomia , Radiometria , Dosagem Radioterapêutica , Planejamento da Radioterapia Assistida por Computador , Estudos Retrospectivos , Taxa de Sobrevida , Resultado do TratamentoRESUMO
OBJECTIVE: To present initial, short-term results obtained with an image-guided radiosurgery apparatus (CyberKnife; Accuray, Inc., Sunnyvale, CA) in a series of 199 benign intracranial meningiomas. METHODS: Selection criteria included lesions unsuitable for surgery and/or remnants after partial surgical removal. All patients were either symptomatic and/or harboring growing tumors. Ninety-nine tumors involved the cavernous sinus; 28 were in the posterior fossa, petrous bone, or clivus; and 29 were in contact with anterior optic pathways. Twenty-two tumors involved the convexity, and 21 involved the falx or tentorium. One hundred fourteen patients had undergone some kind of surgical removal before radiosurgery. Tumor volumes varied from 0.1 to 64 mL (mean, 7.5 mL) and radiation doses ranged from 12 to 25 Gy (mean, 18.5 Gy). Treatment isodoses varied from 70 to 90%. In 150 patients with lesions larger than 8 mL and/or with tumors situated close to critical structures, the dose was delivered in 2 to 5 daily fractions. RESULTS: The follow-up periods ranged from 1 to 59 months (mean, 30 months; median, 30 months). The tumor volume decreased in 36 patients, was unchanged in 148 patients, and increased in 7 patients. Three patients underwent repeated radiosurgery, and 4 underwent operations. One hundred fifty-four patients were clinically stable. In 30 patients, a significant improvement of clinical symptoms was obtained. In 7 patients, neurological deterioration was observed (new cranial deficits in 2, worsened diplopia in 2, visual field reduction in 2, and worsened headache in 2). CONCLUSION: The introduction of the CyberKnife extended the indication to 63 patients (>30%) who could not have been treated by single-session radiosurgical techniques. The procedure proved to be safe. Clinical improvement seems to be more frequently observed with the CyberKnife than in our previous linear accelerator experience.